The use of non‐ablative fractional resurfacing in Asian acne scar patients
Background and Objectives Non‐ablative fractional resurfacing (NA FR) has been shown to be effective for photorejuvenation and acne scarring. Previous studies indicated that density, more than pulse energy, was associated with post‐inflammatory hyperpigmentation (PIH) in Asians. The objective of thi...
Gespeichert in:
Veröffentlicht in: | Lasers in surgery and medicine 2010-12, Vol.42 (10), p.870-875 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background and Objectives
Non‐ablative fractional resurfacing (NA FR) has been shown to be effective for photorejuvenation and acne scarring. Previous studies indicated that density, more than pulse energy, was associated with post‐inflammatory hyperpigmentation (PIH) in Asians. The objective of this retrospective study was to assess the efficacy and complications of eight passes of NA FR (‘full‐NA FR’) with the 1,550 nm erbium‐doped fibre fractional laser (Fraxel SR laser system, Solta Medical, Hayward, CA) versus four passes (‘mini‐NA FR’) with comparable pulse energy and treatment level as ‘full‐NA FR’, but double the number of treatment sessions in Asian acne scar patients.
Materials and Methods
Forty‐seven Asian atrophic facial acne scar patients who received full‐face full‐NA FR or mini‐NA FR treatments between December 2005 and February 2009 were included. All photographic images captured with the Canfield Visia CR system at baseline and follow‐ups were assessed for clinical efficacy and complications by an independent, non‐treating and blinded physician.
Results
The total treatment densities for full‐NA FR and mini‐NA FR were 442.5 and 210.5 MTZ/cm2, respectively. For full‐NA FR, the PIH risk was 18.2% with cross‐polarized images compared to 6.0% for mini‐NA FR. This difference was statistically significant (P |
---|---|
ISSN: | 0196-8092 1096-9101 1096-9101 |
DOI: | 10.1002/lsm.20976 |